MoCRA: what US cosmetic brands should know

Educational content only—not legal, regulatory, or medical advice. Confirm obligations with counsel for your role (manufacturer, packer, distributor, brand).

The Modernization of Cosmetics Regulation Act (MoCRA) expanded FDA expectations for cosmetics sold in the United States: more systematic facility registration, product listing, serious adverse event handling and recordkeeping, and pathways for substance review—all alongside longstanding ingredient prohibitions, restrictions, and truthful labeling rules.

Who does the work when the brand outsources?

Contract manufacturers, brand holders, and importers often split duties. MoCRA asks you to be explicit about which entity registers, lists, maintains safety substantiation, and files adverse events. “We buy turnkey bulk” is not a compliance strategy unless your contracts and QA maps say who owns each FDA-facing obligation.

Product listing ≠ formula approval

Listing provides structured information to FDA; it does not mean FDA approved the formula. You still need a defensible safety story, compliant ingredient use, and accurate claims and labels. Listing and adverse-event infrastructure should connect to your change-control process when ingredients or suppliers change.

State overlays still exist

California and other states maintain additional disclosure or warning concepts (for example substances under spotlight programs). National MoCRA compliance does not automatically erase state labeling questions—your pack copy and supply-chain disclosures need a 50-state sweep where you distribute.

Operational checklist (starting point)

Map legal entity responsible for facility registration and renewal timeline.
Align SKU master data to FDA product listing fields; avoid “legacy” codes that never sync to RA.
Train customer service and medical teams on serious adverse event criteria and escalation.
Tie formula revisions to label panels, INCI order, and any fragrance disclosures (EU allergen guide) for exports.

Use The Molecule Lab workspace for US-restricted lists, state snapshots, fragrance allergens, and formula-scale checks alongside other markets—start at sign in.